Fungal rhinosinusitis: What every allergist should know

Clinical and Experimental Allergy

Volumn 43, Issue 8, 2013, Pages 835-849

  Callejas, C A ^a   Douglas, R G ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CORTICOSTEROID; FLUCONAZOLE; IMMUNOGLOBULIN E; ITRACONAZOLE; STEROID;

ACUTE INVASIVE FUNGAL RHINOSINUSITIS; ACUTE RHINOSINUSITIS; ADJUVANT THERAPY; ALLERGIC FUNGAL RHINOSINUSITIS; ALTERNARIA; ASPERGILLUS; ASPERGILLUS FLAVUS; CHRONIC INVASIVE FUNGAL RHINOSINUSITIS; CLINICAL EXAMINATION; CLINICAL FEATURE; CURVULARIA; DEBRIDEMENT; DIABETIC KETOACIDOSIS; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; ENDOSCOPY; FUNGAL COLONIZATION; FUNGAL SINUSITIS; FUNGUS BALL; GERIATRIC PATIENT; GRANULOMATOSIS; GRANULOMATOUS INVASIVE FUNGAL RHINOSINUSITIS; HUMAN; HYPERSENSITIVITY; IMMUNOCOMPROMISED PATIENT; IMMUNOTHERAPY; IN VITRO STUDY; LABORATORY TEST; LOW DRUG DOSE; MIDDLE AGED; MORTALITY; MOULD; MUCORALES; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; REVIEW; RHINOSINUSITIS; RHIZOPUS; STEROID THERAPY; VIRULENCE;

FUNGI; HUMANS; MYCOSES; RHINITIS; SINUSITIS;

EID: 84880985377     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12118     Document Type: Review

References (136)

1. Montone KT, Livolsi VA, Feldman MD et al. Fungal rhinosinusitis: a retrospective microbiologic and pathologic review of 400 patients at a single university medical center. Int J Otolaryngol 2012; 2012:684835.
2. Michael RC, Michael JS, Ashbee RH, Mathews MS. Mycological profile of fungal sinusitis: an audit of specimens over a 7-year period in a tertiary care hospital in Tamil Nadu. Indian J Pathol Microbiol 2008; 51:493-6.
3. Panda NK, Sharma SC, Chakrabarti A, Mann SB. Paranasal sinus mycoses in north India. Mycoses 1998; 41:281-6.
4. Alexopoulos CJ, Mims CW, Blackwell M. Introductory mycology. 4th Edn. New York: John Wiley and Sons, 1996.
5. Hawksworth DL. The fungal dimension of biodiversity: magnitude, significance, and conservation. Mycol Res 1991; 95:641-55.
6. Blackwell M. The fungi: 1, 2, 3.. 5.1 million species? Am J Bot 2011; 98:426-38.
7. Guarner J, Brandt ME. Histopathologic diagnosis of fungal infections in the 21st century. Clin Microbiol Rev 2011; 24:247-80.
8. Bassiouny A, Ragab A, Attia AF et al. Prevalence of extramucosal fungal elements in sinonasal polyposis: a mycological and pathologic study in an Egyptian population. Am J Otolaryngol 2011; 32:308-17.
9. Moore D, Robson GD, Trinci APJ. 21st Century Guidebook to fungi. 1st Edn. Cambridge: Cambridge University Press, 2011.
10. Burge HA, Pierson DL, Groves TO, Strawn KF, Mishra SK. Dynamics of airborne fungal populations in a large office building. Curr Microbiol 2000; 40:10-6.
11. Gots RE, Layton NJ, Pirages SW. Indoor health: background levels of fungi. AIHA J 2003; 64:427-38.
12. Green BJ, Sercombe JK, Tovey ER. Fungal fragments and undocumented conidia function as new aeroallergen sources. J Allergy Clin Immunol 2005; 115:1043-8.
13. Ebbens FA, Georgalas C, Rinia AB, van Drunen CM, Lund VJ, Fokkens WJ. The fungal debate: where do we stand today? Rhinology 2007; 45:178-89.
14. Barnes PD, Marr KA. Aspergillosis: spectrum of disease, diagnosis, and treatment. Infect Dis Clin North Am 2006; 20:545-61.
15. Revankar SG. Phaeohyphomycosis. Infect Dis Clin North Am 2006; 20:609-20.
16. Hospenthal DR, Kwon-Chung KJ, Bennett JE. Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation. Med Mycol 1998; 36:165-8.
17. Matsumoto T, Ajello L, Matsuda T, Szaniszlo PJ, Walsh TJ. Developments in hyalohyphomycosis and phaeohyphomycosis. J Med Vet Mycol 1994; 32(Suppl 1):329-49.
18. Geiser DM. Sexual structures in Aspergillus: morphology, importance and genomics. Med Mycol 2009; 47(Suppl 1):S21-6.
19. Revankar SG, Sutton DA. Melanized fungi in human disease. Clin Microbiol Rev 2010; 23:884-928.
20. Dixon DM, Polak A, Szaniszlo PJ. Pathogenicity and virulence of wild-type and melanin-deficient Wangiella dermatitidis. J Med Vet Mycol 1987; 25:97-106.
21. McClay JE, Marple B, Kapadia L et al. Clinical presentation of allergic fungal sinusitis in children. Laryngoscope 2002; 112:565-9.
22. Larone DH. Medically important fungi-a guide to identification. 3rd Edn. Washington (DC): American Society for Microbiology Press, 1995.
23. Kontoyiannis DP, Lewis RE. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect Dis Clin North Am 2006; 20:581-607.
24. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000; 13:236-301.
25. Roden MM, Zaoutis TE, Buchanan WL et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41:634-53.
26. Chakrabarti A, Denning DW, Ferguson BJ et al. Fungal rhinosinusitis: a categorization and definitional schema addressing current controversies. Laryngoscope 2009; 119:1809-18.
27. deShazo RD, O'Brien M, Chapin K et al. Criteria for the diagnosis of sinus mycetoma. J Allergy Clin Immunol 1997; 99:475-85.
28. Dufour X, Kauffmann-Lacroix C, Ferrie JC, Goujon JM, Rodier MH, Klossek JM. Paranasal sinus fungus ball: epidemiology, clinical features and diagnosis. A retrospective analysis of 173 cases from a single medical center in France, 1989-2002. Med Mycol 2006; 44:61-7.
29. Gungor A, Adusumilli V, Corey JP. Fungal sinusitis: progression of diseases in immunosuppression-a case report. Ear Nose Throat J 1998; 77:207-11.
30. Legent F, Billet J, Beauvillain C, Bonnet J, Miegeville M. The role of dental canal fillings in the development of Aspergillus sinusitis. A report of 85 cases. Arch Otorhinolaryngol 1989; 246:318-20.
31. Klossek JM, Serrano E, Péloquin L, Percodani J, Fontanel JP, Pessey JJ. Functional endoscopic sinus surgery and 109 mycetomas of paranasal sinuses. Laryngoscope 1997; 107:112-7.
32. Zinreich SJ, Kennedy DW, Malat J et al. Fungal sinusitis: diagnosis with CT and MR imaging. Radiology 1988; 169:439-44.
33. Stammberger H, Jakse R, Beaufort F. Aspergillosis of the paranasal sinuses x-ray diagnosis, histopathology, and clinical aspects. Ann Otol Rhinol Laryngol 1984; 93:251-6.
34. Braun JJ, Bourjat P. CT imaging of fungal and nonfungal caseous sinusitis. A report of 50 cases. J Radiol 2000; 81:227-31.
35. Das A, Bal A, Chakrabarti A, Panda N, Joshi K. Spectrum of fungal rhinosinusitis; histopathologist's perspective. Histopathology 2009; 54:854-9.
36. Fokkens WJ, Lund VJ, Mullol J et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl 2012; 50(Suppl. 23):1-298.
37. Katzenstein AL, Sale SR, Greenberger PA. Allergic Aspergillus sinusitis: a newly recognized form of sinusitis. J Allergy Clin Immunol 1983; 72:89-93.
38. Venarske DL, deShazo RD. Sinobronchial allergic mycosis: the SAM syndrome. Chest 2002; 121:1670-6.
39. Bent JP 3rd, Kuhn FA. Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg 1994; 111:580-8.
40. deShazo RD, Swain RE. Diagnostic criteria for allergic fungal sinusitis. J Allergy Clin Immunol 1995; 96:24-35.
41. Ponikau JU, Sherris DA, Kern EB et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999; 74:877-84.
42. Ferguson BJ. Eosinophilic mucin rhinosinusitis: a distinct clinicopathological entity. Laryngoscope 2000; 110:799-813.
43. Pant H, Kette FE, Smith WB, Wormald PJ, Macardle PJ. Fungal-specific humoral response in eosinophilic mucus chronic rhinosinusitis. Laryngoscope 2005; 115(4):601-6.
44. Collins M, Nair S, Smith W, Kette F, Gillis D, Wormald PJ. Role of local immunoglobulin E production in the pathophysiology of noninvasive fungal sinusitis. Laryngoscope 2004; 114:1242-6.
45. Ferguson BJ, Barnes L, Bernstein JM et al. Geographic variation in allergic fungal rhinosinusitis. Otolaryngol Clin North Am 2000; 33:441-9.
46. Thahim K, Jawaid MA, Marfani MS. Presentation and management of allergic fungal sinusitis. J Coll Physicians Surg Pak 2007; 17:23-7.
47. Khalil Y, Tharwat A, Abdou AG et al. The role of antifungal therapy in the prevention of recurrent allergic fungal rhinosinusitis after functional endoscopic sinus surgery: a randomized, controlled study. Ear Nose Throat J 2011; 90:E1-7.
48. Wise SK, Ghegan MD, Gorham E, Schlosser RJ. Socioeconomic factors in the diagnosis of allergic fungal rhinosinusitis. Otolaryngol Head Neck Surg 2008; 138:38-42.
49. Aimanianda V, Bayry J, Bozza S et al. Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature 2009; 460:1117-21.
50. Schubert MS, Hutcheson PS, Graff RJ, Santiago L, Slavin RG. HLA-DQB1*03 in allergic fungal sinusitis and other chronic hypertrophic rhinosinusitis disorders. J Allergy Clin Immunol 2004; 114:1376-83.
51. Manning SC, Vuitch F, Weinberg AG, Brown OE. Allergic Aspergillosis: a newly recognized form of sinusitis in the pediatric population. Laryngoscope 1989; 99:681-5.
52. Marple BF, Gibbs SR, Newcomer MT, Mabry RL. Allergic fungal sinusitis-induced visual loss. Am J Rhinol 1999; 13:191-5.
53. Al-Radadi AM, Alnoury KI. Optic chiasma involvement secondary to allergic fungal rhinosinusitis. J Pak Med Assoc 2011; 61:704-7.
54. Manning SC, Merkel M, Kriesel K, Vuitch F, Marple B. Computed tomography and magnetic resonance diagnosis of allergic fungal sinusitis. Laryngoscope 1997; 107:170-6.
55. Ghegan MD, Lee FS, Schlosser RJ. Incidence of skull base and orbital erosion in allergic fungal rhinosinusitis (AFRS) and non-AFRS. Otolaryngol Head Neck Surg 2006; 134:592-5.
56. Al-Dousary SH. Allergic fungal sinusitis: radiological and microbiological features of 59 cases. Ann Saudi Med 2008; 28:17-21.
57. Schubert MS, Goetz DW. Evaluation and treatment of allergic fungal sinusitis. I. Demographics and diagnosis. J Allergy Clin Immunol 1998; 102:387-94.
58. Mabry RL, Mabry CS. Immunotherapy for allergic fungal sinusitis: the second year. Otolaryngol Head Neck Surg 1997; 117:367-71.
59. Chambers DW, Cook PR, Nishioka GJ, Erhart P. Comparison of mRAST and CAP with skin end point titration for Alternaria tenuis and dermatophagoides pteronyssinus. Otolaryngol Head Neck Surg 1997; 117:471-4.
60. Mabry RL, Marple BF, Mabry CS. Mold testing by RAST and skin test methods in patients with allergic fungal sinusitis. Otolaryngol Head Neck Surg 1999; 121:252-4.
61. Corey JP. In vitro allergy testing. Curr Opin Otolaryngol Head Neck Surg 1994; 2:128-36.
62. Nalebuff DJ, Fadal RG. The modified RAST assay: an aid in the diagnosis and management of allergic disorders. Continuing Education for the Family Physician 1979; 10:65-76.
63. Tandy JR, Mabry RL, Mabry CS. Correlation of modified radioallergosorbent test scores and skin test results. Otolaryngol Head Neck Surg 1996; 115:42-5.
64. Stewart AE, Hunsaker DH. Fungus-specific IgG and IgE in allergic fungal rhinosinusitis. Otolaryngol Head Neck Surg 2002; 127:324-32.
65. Manning SC, Mabry RL, Schaefer SD, Close LG. Evidence of IgE-mediated hypersensitivity in allergic fungal sinusitis. Laryngoscope 1993; 103:717-21.
66. Chrzanowski RR, Rupp NT, Kuhn FA, Phillips AE, Dolen WK. Allergenic fungi in allergic fungal sinusitis. Ann Allergy Asthma Immunol 1997; 79:431-5.
67. Telmesani LM. Prevalence of allergic fungal sinusitis among patients with nasal polyps. Ann Saudi Med 2009; 29:212-4.
68. Ricketti AJ, Greenberger PA, Patterson R. Serum IgE as an important aid in the management of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1984; 74:68-71.
69. Patterson R, Fink JN, Pruzansky JJ et al. Serum immunoglobulin levels in pulmonary allergic aspergillosis and certain other lung diseases, with special reference to immunoglobulin E. Am J Med 1973; 54:16-22.
70. Schubert MS, Goetz DW. Evaluation and treatment of allergic fungal sinusitis. II. Treatment and follow-up. J Allergy Clin Immunol 1998; 102:395-402.
71. Manning SC, Holman M. Further evidence for allergic pathophysiology in allergic fungal sinusitis. Laryngoscope 1998; 108:1485-96.
72. Waxman JE, Spector JG, Sale SR, Katzenstein AL. Allergic Aspergillus sinusitis: concepts in diagnosis and treatment of a new clinical entity. Laryngoscope 1987; 97:261-6.
73. Gourley DS, Whisman BA, Martin ME, Reid MJ. Clinical and immunological characteristics of allergic fungal sinusitis caused by Bipolaris spicifera. J Allergy Clin Immunol 1988; 81:285.
74. Chauhan B, Santiago L, Kirschmann DA et al. The association of HLA-DR alleles and T cell activation with allergic bronchopulmonary aspergillosis. J Immunol 1997; 159:4072-6.
75. Chauhan B, Knutsen Ap, Hutcheson PS, Slavin RG, Bellone CJ. T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis. J Clin Invest 1996; 97:2324-31.
76. Slavin RG, Fischer VW, Levine EA, Tsai CC, Winzenburger P. A primate model of allergic bronchopulmonary aspergillosis. Int Arch Allergy Appl Immunol 1978; 5:325-33.
77. McCarthy DS, Pepys J. Allergic broncho-pulmonary aspergillosis. Clinical immunology. 2. Skin, nasal and bronchial tests. Clin Allergy 1971; 1:415-32.
78. Luong A, Davis LS, Marple BF. Peripheral blood mononuclear cells from allergic fungal rhinosinusitis adults express a Th2 cytokine response to fungal antigens. Am J Rhinol Allergy 2009; 23:281-7.
79. Knutsen AP. Cell-mediated immunity in allergic bronchopulmonary aspergillosis. Immunol Allergy Clin North Am 1998; 18:575-99.
80. Bains SN, Judson MA. Allergic bronchopulmonary aspergillosis. Clin Chest Med 2012; 33:265-81.
81. Javer AR, Genoway KA, Gervais M, Romney M, Zemcov J. Fungal cultures in patients with allergic fungal rhinosinusitis: improving the recovery of potential fungal pathogens in the Canadian laboratory. J Otolaryngol 2007; 36:1-5.
82. Perez-Jaffe LA, Lanza DC, Loevner LA, Kennedy DW, Montone KT. In situ hybridization for Aspergillus and Penicillium in allergic fungal sinusitis: a rapid means of speciating fungal pathogens in tissues. Laryngoscope 1997; 107:233-40.
83. Montone KT, Livolsi VA, Lanza DC et al. Rapid In-situ hybridization for dematiaceous fungi using a broad-spectrum oligonucleotide DNA probe. Diagn Mol Pathol 2011; 20:180-3.
84. Ashraf MJ, Azarpira N, Badiee P, Khademi B, Shishegar M. Fungal characterization using polymerase chain reaction in patients with fungal sinusitis. Indian J Pathol Microbiol 2011; 54:415-7.
85. El-Morsy SM, Khafagy YW, El-Naggar MM, Beih AA. Allergic fungal rhinosinusitis: detection of fungal DNA in sinus aspirate using polymerase chain reaction. J Laryngol Otol 2010; 124:152-60.
86. Taylor MJ, Ponikau JU, Sherris DA et al. Detection of fungal organisms in eosinophilic mucin using a fluorescein-labeled chitin-specific binding protein. Otolaryngol Head Neck Surg 2002; 127:377-83.
87. Kimura M, McGinnis MR. Fontana-Masson-stained tissue from culture-proven mycoses. Arch Pathol Lab Med 1998; 122:1107-11.
88. Senior BA, Kennedy DW, Tanabodee J, Kroger H, Hassab M, Lanza D. Long-term results of functional endoscopic sinus surgery. Laryngoscope 1998; 108:151-7.
89. Rupa V, Jacob M, Mathews MS, Seshadri MS. A prospective, randomised, placebo-controlled trial of postoperative oral steroid in allergic fungal sinusitis. Eur Arch Otorhinolaryngol 2010; 267:233-8.
90. Kupferberg SB, Bent JP 3rd, Kuhn FA. Prognosis for allergic fungal sinusitis. Otolaryngol Head Neck Surg 1997; 117:35-41.
91. Bassichis BA, Marple BF, Mabry RL, Newcomer MT, Schwade ND. Use of immunotherapy in previously treated patients with allergic fungal sinusitis. Otolaryngol Head Neck Surg 2001; 125:487-90.
92. Marple B, Newcomer M, Schwade N, Mabry R. Natural history of allergic fungal rhinosinusitis: a 4- to 10-year follow-up. Otolaryngol Head Neck Surg 2002; 127:361-6.
93. Folker RJ, Marple BF, Mabry RL, Mabry CS. Treatment of allergic fungal sinusitis: a comparison trial of postoperative immunotherapy with specific fungal antigens. Laryngoscope 1998; 108:1623-7.
94. Greenhaw B, deShazo RD, Arnold J, Wright L. Fungal immunotherapy in patients with allergic fungal sinusitis. Ann Allergy Asthma Immunol 2011; 107:432-6.
95. Sacks PL, Harvey RJ, Rimme J, Gallagher RM, Sacks R. Topical and systemic antifungal therapy for the symptomatic treatment of chronic rhinosinusitis. Cochrane Database Syst Rev 2011; 8:CD008263.
96. Jen A, Kacker A, Huang C, Anand V. Fluconazole nasal spray in the treatment of allergic fungal sinusitis: a pilot study. Ear Nose Throat J 2004; 83:692.
97. Chan KO, Genoway KA, Javer AR. Effectiveness of itraconazole in the management of refractory allergic fungal rhinosinusitis. J Otolaryngol Head Neck Surg 2008; 37:870-4.
98. Rains BM 3rd, Mineck CW. Treatment of allergic fungal sinusitis with high-dose itraconazole. Am J Rhinol 2003; 17:1-8.
99. Seiberling K, Wormald PJ. The role of itraconazole in recalcitrant fungal sinusitis. Am J Rhinol Allergy 2009; 23:303-6.
100. Andes D, Proctor R, Bush RK, Pasic TR. Report of successful prolonged antifungal therapy for refractory allergic fungal sinusitis. Clin Infect Dis 2000; 31:202-4.
101. Erwin GE, Fitzgerald JE. Case report: allergic bronchopulmonary aspergillosis and allergic fungal sinusitis successfully treated with voriconazole. J Asthma 2007; 44:891-5.
102. Stevens DA, Schwartz HJ, Lee JY et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000; 342:756-62.
103. Wark PA, Hensley MJ, Saltos N et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 2003; 111:952-7.
104. Wark PA, Gibson PG, Wilson AJ. Azoles for allergic bronchopulmonary aspergillosis associated with asthma. Cochrane Database Syst Rev 2004; 3:CD001108.
105. Hilliard T, Edwards S, Buchdahl R et al. Voriconazole therapy in children with cystic fibrosis. J Cyst Fibros 2005; 4:215-20.
106. Glackin L, Leen G, Elnazir B, Greally P. Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis. Ir Med J 2009; 102:29.
107. Chishimba L, Niven RM, Cooley J, Denning DW. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. J Asthma 2012; 49:423-33.
108. van der Ent CK, Hoekstra H, Rijkers GT. Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody. Thorax 2007; 62:276-7.
109. Zirbes JM, Milla CE. Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis. Pediatr Pulmonol 2008; 43:607-10.
110. Kanu A, Patel K. Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab). Pediatr Pulmonol 2008; 43:1249-51.
111. ElMallah MK, Hendeles L, Hamilton RG, Capen C, Schuler PM. Management of patients with cystic fibrosis and allergic bronchopulmonary aspergillosis using anti-immunoglobulin E therapy (omalizumab). J Pediatr Pharmacol Ther 2012; 17:88-92.
112. Grundmann SA, Hemfort PB, Luger TA, Brehler R. Anti-IgE (omalizumab): a new therapeutic approach for chronic rhinosinusitis. J Allergy Clin Immunol 2008; 121:257-8.
113. Guglielmo M, Gulotta C, Mancini F, Sacchi M, Tarantini F. Recalcitrant nasal polyposis: achievement of total remission following treatment with omalizumab. J Investig Allergol Clin Immunol 2009; 19:158-9.
114. Pinto JM, Mehta N, DeTineo M, Wang J, Baroody FM, Naclerio RM. A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinology 2010; 48:318-24.
115. Larsen K, von Buchwald C, Ellefsen B, Francis D. Unexpected expansive paranasal sinus mucormycosis. ORL J Otorhinolaryngol Relat Spec 2003; 65:57-60.
116. Mignogna MD, Fortuna G, Leuci S et al. Mucormycosis in immunocompetent patients: a case-series of patients with maxillary sinus involvement and a critical review of the literature. Int J Infect Dis 2011; 15:e533-40.
117. Fleming RV, Walsh TJ, Anaissi EJ. Emerging and less common fungal pathogens. Infect Dis Clin North Am 2002; 16:915-33.
118. Chander J, Chakrabarti A, Sharma A, Saini JS, Panigarhi D. Evaluation of Calcofluor staining in the diagnosis of fungal corneal ulcer. Mycoses 1993; 36:243-5.
119. deShazo RD, O'Brien M, Chapin K, Soto-Aguilar M, Gardner L, Swain R. A new classification and diagnostic criteria for invasive fungal sinusitis. Arch Otolaryngol Head Neck Surg 1997; 123:1181-8.
120. Mennink-Kersten MA, Verweij PE. Non-culture-based diagnostics for opportunistic fungi. Infect Dis Clin North Am 2006; 20:711-27.
121. Silverman CS, Mancuso AA. Periantral soft-tissue infiltration and its relevance to the early detection of invasive fungal sinusitis: CT and MR findings. AJNR Am J Neuroradiol 1998; 19:321-5.
122. DelGaudio JM, Swain RE Jr, Kingdom TT, Muller S, Hudgins PA. Computed tomographic findings in patients with invasive fungal sinusitis. Arch Otolaryngol Head Neck Surg 2003; 129:236-40.
123. Finkelstein A, Contreras D, Pardo J et al. Paranasal sinuses computed tomography in the initial evaluation of patients with suspected invasive fungal rhinosinusitis. Eur Arch Otorhinolaryngol 2011; 268:1157-62.
124. Trasmonte MV, Jiménez JD, Santiago MÁ et al. Association of topical amphotericin B lipid complex treatment to standard therapy for rhinomaxillary mucormycosis after liver transplantation: a case report. Transplant Proc 2012; 44:2120-3.
125. Saedi B, Sadeghi M, Seilani P. Endoscopic management of rhinocerebral mucormycosis with topical and intravenous amphotericin B. J Laryngol Otol 2011; 125:807-10.
126. Herbrecht R, Denning DW, Patterson TF et al. Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347:408-15.
127. Walsh TJ, Anaissie EJ, Denning DW et al. Infectious Diseases Society of America.Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46:327-60.
128. Smith J, Safdar N, Knasinski V et al. Voriconazole therapeutic drug monitoring. Antimicrob Agents Chemother 2006; 50:1570-2.
129. Chandrasekar P. Invasive mold infections: recent advances in management approaches. Leuk Lymphoma 2009; 50:703-15.
130. Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev 2007; 20:695-704.
131. DelGaudio JM, Clemson LA. An early detection protocol for invasive fungal sinusitis in neutropenic patients successfully reduces extent of disease at presentation and long term morbidity. Laryngoscope 2009; 119:180-3.
132. Valera FC, do Lago T, Tamashiro E, Yassuda CC, Silveira F, Anselmo-Lima WT. Prognosis of acute invasive fungal rhinosinusitis related to underlying disease. Int J Infect Dis 2011; 15:e841-4.
133. Kasapoglu F, Coskun H, Ozmen OA, Akalin H, Ener B. Acute invasive fungal rhinosinusitis: evaluation of 26 patients treated with endonasal or open surgical procedures. Otolaryngol Head Neck Surg 2010; 143:614-20.
134. Li Y, Li Y, Li P, Zhang G. Diagnosis and endoscopic surgery of chronic invasive fungal rhinosinusitis. Am J Rhinol Allergy 2009; 23:622-5.
135. Challa S, Uppin SG, Hanumanthu S et al. Fungal rhinosinusitis: a clinicopathological study from South India. Eur Arch Otorhinolaryngol 2010; 267:1239-45.
136. Gumaa SA, Mahgoub ES, Hay RJ. Post-operative responses of paranasal Aspergillus granuloma to itraconazole. Trans R Soc Trop Med Hyg 1992; 86:93-4.